Head-To-Head Comparison: ADB International Group (OTCMKTS:EQUR) and Enovis (NYSE:ENOV)

Enovis (NYSE:ENOV) and ADB International Group (OTCMKTS:EQUR) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation.

Insider & Institutional Ownership

98.5% of Enovis shares are held by institutional investors. 2.9% of Enovis shares are held by insiders. Comparatively, 79.6% of ADB International Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Valuation and Earnings

This table compares Enovis and ADB International Group”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Enovis	$2.25 billion	0.62	-$1.18 billion	($19.26)	-1.26
ADB International Group	N/A	N/A	N/A	N/A	N/A

ADB International Group has lower revenue, but higher earnings than Enovis.

Analyst Ratings

This is a summary of current ratings and target prices for Enovis and ADB International Group, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Enovis	1	1	8	0	2.70
ADB International Group	0	0	0	0	0.00

Enovis presently has a consensus price target of $42.00, indicating a potential upside of 73.20%. Given Enovis’ stronger consensus rating and higher probable upside, equities research analysts plainly believe Enovis is more favorable than ADB International Group.

Profitability

This table compares Enovis and ADB International Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Enovis	-47.96%	12.03%	4.91%
ADB International Group	N/A	N/A	N/A

Summary

Enovis beats ADB International Group on 7 of the 9 factors compared between the two stocks.

About Enovis

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

About ADB International Group

E-Qure Corp., a medical device company, focuses on the development and commercialization of bioelectrical signal therapy (BST) devices. Its BST devices implement patented and proprietary electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure. The company was incorporated in 1988 and is based in New York, New York.